Nir Ben‐Chetrit
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Oncology top 10%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Epigenetics and DNA Methylation 2
- Glycosylation and Glycoproteins Research 2
- Oncology 8
- HER2/EGFR in Cancer Research 5
- Cancer Cells and Metastasis 3
- Co-authors
- Yosef Yarden (9 shared papers)Johanna A. Joyce (3 shared papers)Hadas Cohen‐Dvashi (5 shared papers)Sara Lavi (4 shared papers)Andrew J. Dannenberg (1 shared paper)I‐Chun Chen (1 shared paper)Daniela A. Ferraro (3 shared papers)Oakley C. Olson (1 shared paper)
- Journals
- Oncogene (4 papers)Nature Communications (2 papers)PLoS ONE (2 papers)Science Signaling (1 paper)Scientific Reports (1 paper)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Nir Ben‐Chetrit
15 papers receiving 889 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 210
- Oncology 353
- Immunology 187
- Molecular Biology 474
- Immunology and Allergy 38
Countries citing papers authored by Nir Ben‐Chetrit
This map shows the geographic impact of Nir Ben‐Chetrit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nir Ben‐Chetrit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nir Ben‐Chetrit more than expected).
Fields of papers citing papers by Nir Ben‐Chetrit
This network shows the impact of papers produced by Nir Ben‐Chetrit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nir Ben‐Chetrit. The network helps show where Nir Ben‐Chetrit may publish in the future.
Co-authors
The 25 scholars most cited alongside Nir Ben‐Chetrit, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 198 | |
| 2 | 2016 | 102 | |
| 3 | 2013 | 93 | |
| 4 | 2011 | 82 | |
| 5 | 2011 | 78 | |
| 6 | 2015 | 77 | |
| 7 | 2014 | 49 | |
| 8 | 2014 | 43 | |
| 9 | 2022 | 35 | |
| 10 | 2011 | 31 | |
| 11 | 2017 | 28 | |
| 12 | 2019 | 27 | |
| 13 | 2011 | 25 | |
| 14 | 2013 | 14 | |
| 15 | 2010 | 14 |
About Nir Ben‐Chetrit
Nir Ben‐Chetrit is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Cell Biology, having authored 15 papers that have together received 896 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer Cells and Metastasis (3 papers), Immune cells in cancer (3 papers), Epigenetics and DNA Methylation (2 papers), Glycosylation and Glycoproteins Research (2 papers), MicroRNA in disease regulation (1 paper) and Mesenchymal stem cell research (1 paper). The work is most often cited by research in Cancer Research (210 citations), Oncology (353 citations), Immunology (187 citations), Molecular Biology (474 citations) and Immunology and Allergy (38 citations). Nir Ben‐Chetrit has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Yosef Yarden, Johanna A. Joyce, Hadas Cohen‐Dvashi, Sara Lavi, Andrew J. Dannenberg, I‐Chun Chen, Daniela A. Ferraro, Oakley C. Olson, Logan A. Walsh and Peter R. Holt. Their work appears in journals such as Oncogene, Nature Communications, PLoS ONE, Science Signaling and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.